Primary aldosteronism (PA) is one the single most common causes of hypertension, but identifying patients with PA—and knowing which ones may benefit from a surgical treatment—can be quite challenging.

The FDA is reclassifying interventional cardiovascular implant simulation software into the class II (special controls) regulatory category, which will make it easier for the technology to pass regulatory approval. 

Juan Granada, MD, president and CEO of the Cardiovascular Research Foundation (CRF), shares his thoughts on two key areas of technology advancements in cardiovascular imaging and neuro-interventional care for stroke.

Read our recap of some of the biggest FDA-related stories that impacted cardiology in the last month.

James Udelson, MD, an investigator involved with the PRECISE trial, explained how patient outcomes were improved by 70% from the current standard of care.

Suhny Abbara, MD, editor of Radiology: Cardiothoracic Imaging and chief of cardiothoracic imaging for University of Texas Southwestern Medical Center, discusses how spectral computed tomography (CT) can help both cardiac and general CT imaging.

The new study, presented at the AHA Scientific Sessions 2022 conference in Chicago, focused on data from more than 2,000 patients. 

Ed Nicol, MD, MBA, president-elect of the Society of Cardiovascular Computed Tomography, discusses what he sees as the big technology advances in cardiac CT.